On the possibility of improving the efficiency of cancer recognition and eradication in vivo when concurrently using two different types of nanodevices

When using nanodevices in oncology, it is necessary to provide efficiency of the performance of these nanodevices simultaneously with their safety for an organism. These are conflicting objectives to some extent. Nevertheless, as shown in this work, an approach that helps to eliminate this contradiction is offered. For recognition and destruction of cancer cells in vivo it is suggested to use, instead of one type, simultaneously two types of specialized nanodevices interacting with each other introduced into an organism. Some of the nanodevices only recognize cancer cells, while other ones, that cannot recognize them, find cells being marked by nanodevices of the first type, and destroy them. This makes it possible to increase the reliability of the cancer cell recognition process on the one hand, and have the process of their destruction rather safe for an organism on the other hand.